U
URO-1
Early stage medical products developer for urology procedures
About URO-1
URO 1 is an emerging medical device company specializing in the development of disposable products for office procedures in the fields of urogynecology and urology. The company's inaugural product, the Bladder Injection System, has recently received clearance from the US FDA. This system is specifically designed to minimize complications following onabotulinumtoxinA treatment for overactive bladder (OAB) in women. Key features include a unique memory cannula platform and a no-look self-metering syringe, which aim to enhance the precision and safety of the procedure. URO 1 primarily serves healthcare providers specializing in urogynecology and urology, operating within the medical device market. The company's business model revolves around the development, patenting, and commercialization of innovative medical devices. Revenue is generated through the sale of these disposable products to medical professionals and healthcare institutions. Additional products are currently in late-stage development, indicating a pipeline of future offerings that could further expand the company's market presence.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- Greensboro, United States
- Sector
- Health Tech & Medtech
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Acorn
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about URO-1 on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See URO-1 on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.